Direct visualization of alpha-synuclein oligomers reveals previously undetected pathology in Parkinson's disease brain

Brain : a Journal of Neurology
Rosalind F RobertsJ Alegre-Abarrategui

Abstract

Oligomeric forms of alpha-synuclein are emerging as key mediators of pathogenesis in Parkinson's disease. Our understanding of the exact contribution of alpha-synuclein oligomers to disease is limited by the lack of a technique for their specific detection. We describe a novel method, the alpha-synuclein proximity ligation assay, which specifically recognizes alpha-synuclein oligomers. In a blinded study with post-mortem brain tissue from patients with Parkinson's disease (n = 8, age range 73-92 years, four males and four females) and age- and sex-matched controls (n = 8), we show that the alpha-synuclein proximity ligation assay reveals previously unrecognized pathology in the form of extensive diffuse deposition of alpha-synuclein oligomers. These oligomers are often localized, in the absence of Lewy bodies, to neuroanatomical regions mildly affected in Parkinson's disease. Diffuse alpha-synuclein proximity ligation assay signal is significantly more abundant in patients compared to controls in regions including the cingulate cortex (1.6-fold increase) and the reticular formation of the medulla (6.5-fold increase). In addition, the alpha-synuclein proximity ligation assay labels very early perikaryal aggregates in morphologic...Continue Reading

References

May 24, 1978·Acta Neuropathologica·K Kosaka
Jan 1, 1992·Acta Neuropathologica·G E DaleP N Leigh
May 23, 1994·FEBS Letters·R JakesM Goedert
Dec 1, 1996·Current Opinion in Neurology·G Forloni
Aug 28, 1997·Nature·M G SpillantiniM Goedert
Apr 26, 2000·Proceedings of the National Academy of Sciences of the United States of America·L C SerpellR A Crowther
Mar 15, 2002·The Journal of Biological Chemistry·Hirotomo MiakeMasato Hasegawa
Jul 19, 2002·Nature·Hilal A LashuelPeter T Lansbury
Dec 25, 2002·Neurobiology of Aging·Heiko BraakEva Braak
Jul 23, 2003·Journal of the Neurological Sciences·Richard H C LazeronPhilip Scheltens
Aug 19, 2003·The Journal of Biological Chemistry·George K TofarisMaria Grazia Spillantini
Dec 25, 2003·Journal of Neuropathology and Experimental Neurology·Erkki KuusistoIrina Alafuzoff
Feb 3, 2004·Annals of Neurology·Juan J ZarranzJusto G de Yebenes
Dec 31, 2004·Journal of Neuropathology and Experimental Neurology·Manuela NeumannPhilipp J Kahle
Oct 13, 2005·Proteomics·Ilka Wittig, Hermann Schägger
Nov 24, 2005·Journal of Molecular Biology·Mihaela M ApetriVernon E Anderson
Mar 2, 2006·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Omar M A El-AgnafDavid Allsop
Feb 9, 2007·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Michael L Kramer, Walter J Schulz-Schaeffer
Mar 22, 2007·Biochemical and Biophysical Research Communications·Leo ChenJing Zhang
Aug 24, 2007·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Karin M DanzerMarcus Kostka
Feb 13, 2008·Archives of Neurology·Claudio Soto, Lisbell D Estrada
Apr 3, 2008·PloS One·Tiago Fleming OuteiroPamela J McLean
Apr 26, 2008·The Journal of Biological Chemistry·Julie E TetzlaffPamela J McLean
Aug 22, 2008·Neurobiology of Aging·Evangelia EmmanouilidouKostas Vekrellis
Sep 16, 2008·Journal of the American Chemical Society·Jennifer L CzlapinskiCarolyn R Bertozzi
Aug 5, 2009·Proceedings of the National Academy of Sciences of the United States of America·Paula DesplatsSeung-Jae Lee
Sep 16, 2009·Journal of Virological Methods·Joerg SchlingemannSándor Belák
Nov 6, 2009·Journal of the American Chemical Society·Hai-Young KimMarkus Zweckstetter
Mar 24, 2010·Nature Reviews. Molecular Cell Biology·Patrik BrundinRon Kopito
Jun 12, 2010·Expert Review of Proteomics·Irene WeibrechtOla Söderberg
Oct 7, 2010·BMC Neuroscience·Masood Kamali-MoghaddamUlf Landegren

❮ Previous
Next ❯

Citations

Jul 3, 2015·Expert Opinion on Therapeutic Targets·Nada B LawandBared Safieh-Garabedian
Aug 22, 2015·Expert Review of Neurotherapeutics·Kurt A Jellinger
Feb 6, 2016·International Journal of Molecular Sciences·Gabor G Kovacs
Dec 26, 2015·Movement Disorders : Official Journal of the Movement Disorder Society·Ann-Louise BergströmKarina Fog
Jan 23, 2016·Movement Disorders : Official Journal of the Movement Disorder Society·Claudio Ruffmann, Laura Parkkinen
Sep 5, 2015·Movement Disorders : Official Journal of the Movement Disorder Society·Heather McCannGlenda M Halliday
Jan 23, 2016·Movement Disorders : Official Journal of the Movement Disorder Society·Laura CaloMaria Grazia Spillantini
Jan 20, 2016·Nature Reviews. Neurology·Lorraine V Kalia, Anthony E Lang
Feb 24, 2016·Movement Disorders : Official Journal of the Movement Disorder Society·Ledia F Hernández
Oct 28, 2015·The European Journal of Neuroscience·Rosalind F Roberts, Richard Wade-Martins
Aug 1, 2015·Movement Disorders : Official Journal of the Movement Disorder Society·Caroline Williams-Gray
Nov 28, 2015·Neuropathology and Applied Neurobiology·Arianna BellucciPierFranco Spano
Sep 26, 2015·Journal of Parkinson's Disease·Sonia George, Patrik Brundin
Jul 21, 2015·Journal of Neurochemistry·Anna Villar-PiquéTiago Fleming Outeiro
May 28, 2015·Brain : a Journal of Neurology·Ulf Dettmer, Tim Bartels
Mar 27, 2016·Annals of Neurology·Morten Gersel StokholmPer Borghammer
Jul 28, 2016·Proceedings of the National Academy of Sciences of the United States of America·Timothy S JarvelaIris Lindberg
Mar 29, 2016·Journal of Neurochemistry·Laura A Volpicelli-DaleyAshley S Harms
Mar 1, 2016·Journal of Neurochemistry·Wouter Peelaerts, Veerle Baekelandt
Sep 22, 2016·Critical Reviews in Biochemistry and Molecular Biology·Julia E GersonRakez Kayed
Jan 12, 2017·ACS Chemical Neuroscience·Liang XuDamien Thompson
Mar 30, 2017·Biomarkers in Medicine·Naomi P VisanjiUNKNOWN Systemic Synuclein Sampling Study (S4)
Feb 16, 2017·Frontiers in Molecular Neuroscience·Nadia CanuPietro Calissano
Aug 1, 2018·International Journal of Molecular Sciences·Larisa RyskalinFrancesco Fornai
Jan 14, 2018·Brain Pathology·Francesca LonghenaArianna Bellucci
Mar 16, 2019·Expert Opinion on Therapeutic Targets·Iryna Prots, Beate Winner
Jul 3, 2019·Journal of Neurochemistry·Marion DelenclosPamela J McLean
Jun 14, 2019·The Journal of Clinical Investigation·Ruth E MusgroveDonato A Di Monte
Aug 4, 2019·Annals of Neurology·Ivan Martinez-ValbuenaMaria-Rosario Luquin
Mar 3, 2020·Critical Reviews in Clinical Laboratory Sciences·Darren M O'HaraLorraine V Kalia
Sep 12, 2019·Translational Neurodegeneration·Naomi P VisanjiGabor G Kovacs
Sep 29, 2020·Nature Communications·Nora Bengoa-VergnioryRichard Wade-Martins

❮ Previous
Next ❯

Methods Mentioned

BETA
proximity ligation assay
fluorescence resonance
transfection
bimolecular
fluorescence complementation assay
PCR
electron microscopy

Software Mentioned

PLA
AS

Related Concepts

Related Feeds

Alpha-Synuclein Aggregation

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.

Alpha-Synuclein Aggregation (MDS)

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.